FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W108278987> ?p ?o ?g. }

• W108278987 abstract "Minority HIV-1 drug resistance bas not been studied in Thailand. Two groups of patients, whose conventional genotyping results showed no drug resistance-associated mutations, were investigated: 104 homosexual men recently infected with HIV-1, naive to antiretroviral treatment and 22 first-line NNRTI-based failures. Pyrosequencing assay was developed to detect and quantify minority Y181C and M184V variants from the patients' plasma samples. 1/104 (0. 96%) and 3/101 (3%) samples were found harboring Y181C and M184V in the group of homosexual men. In patients with first-line treatment failure, one harbored minority Ml84V mutants (4. 5%). Thus, due to such a low prevalence, minority drug resistance test may not be cost-effective for implementing in Thailand. The mechanism of raltegravir (RAL)-resistant evolutions has not been completely elucidated. Because of the emergence of RAL resistance usually initiated with the N155H mutant, we assessed the role of minority N155H-mutated variants in circulating RNA and archived DNA in 5 heavily treated patients experiencing RAL failure and harboring 3 different resistance profiles. No minority N155H-mutated variant was found by allele specific PCR (AS-PCR) in both plasma and whole blood samples collected at baseline and after RAL withdrawal in ail 5 patients. During RAL failure, the mutation N155H was detected at different levels in 3 patients displaying the N155H pathway and gradually declined when the double mutant Q148H+G140S was selected in one patient. In two patients with the Q148H resistance pathway, no N155H variant was identified by AS-PCR in both viral RNA and DNA. The N155H mutants might not play a role in determining different resistance profiles. The genetic barrier, defined by the accumulative number of drug-associated mutations required for the virus to escape drug-selective pressure, is a crucial factor in the development of drug resistance. There are limited data on subtype CRJF01_AE, a predominant isolate in Southeast Asia. The genetic barrier for the evolution of integrase inhibitors (INIs) including RAL, elvitegravir (EVG), and dolutegravir (DTG) resistance was compared between HIV-1 subtypes B and CRF01_AE by analyzing of 66 substitutions associated with INI resistance at 41 amino acid positions in 144 nucleotide sequences (109 HIV-1 subtype CRF01_AE and 35 HIV-1 subtype B) of IN gene derived from INI-naive patients. Most studied amino acid positions including ail corresponding to RAL and EVG primary mutations show a high degree of conservation, indicating the same genetic barrier between subtypes CRF01_AE and B. Nevertheless, different genetic barriers were observed in two mutations described to be associated with DTG resistance (L101I, A124T) and other five RAL and EVG secondary mutations (V72I, T125K, G140C/S, V201I), which could have an impact on the development of resistance to RAL, EVG, and DTG." @default.
• W108278987 created "2016-06-24" @default.
• W108278987 creator A5057940393 @default.
• W108278987 date "2012-01-01" @default.
• W108278987 modified "2023-09-23" @default.
• W108278987 title "HIV-1 minority variants associated with drug resistance to reverse transcriptase and integrase inhibitors and genetic barrier for the development of resistance to integrase inhibitors" @default.
• W108278987 hasPublicationYear "2012" @default.
• W108278987 type Work @default.
• W108278987 sameAs 108278987 @default.
• W108278987 citedByCount "0" @default.
• W108278987 crossrefType "dissertation" @default.
• W108278987 hasAuthorship W108278987A5057940393 @default.
• W108278987 hasConcept C104317684 @default.
• W108278987 hasConcept C114851261 @default.
• W108278987 hasConcept C135763542 @default.
• W108278987 hasConcept C142462285 @default.
• W108278987 hasConcept C143065580 @default.
• W108278987 hasConcept C14430832 @default.
• W108278987 hasConcept C156719811 @default.
• W108278987 hasConcept C159047783 @default.
• W108278987 hasConcept C182707283 @default.
• W108278987 hasConcept C2777302000 @default.
• W108278987 hasConcept C2779502633 @default.
• W108278987 hasConcept C2780404665 @default.
• W108278987 hasConcept C2993143319 @default.
• W108278987 hasConcept C3013748606 @default.
• W108278987 hasConcept C31467283 @default.
• W108278987 hasConcept C501734568 @default.
• W108278987 hasConcept C54355233 @default.
• W108278987 hasConcept C67705224 @default.
• W108278987 hasConcept C71924100 @default.
• W108278987 hasConcept C86803240 @default.
• W108278987 hasConceptScore W108278987C104317684 @default.
• W108278987 hasConceptScore W108278987C114851261 @default.
• W108278987 hasConceptScore W108278987C135763542 @default.
• W108278987 hasConceptScore W108278987C142462285 @default.
• W108278987 hasConceptScore W108278987C143065580 @default.
• W108278987 hasConceptScore W108278987C14430832 @default.
• W108278987 hasConceptScore W108278987C156719811 @default.
• W108278987 hasConceptScore W108278987C159047783 @default.
• W108278987 hasConceptScore W108278987C182707283 @default.
• W108278987 hasConceptScore W108278987C2777302000 @default.
• W108278987 hasConceptScore W108278987C2779502633 @default.
• W108278987 hasConceptScore W108278987C2780404665 @default.
• W108278987 hasConceptScore W108278987C2993143319 @default.
• W108278987 hasConceptScore W108278987C3013748606 @default.
• W108278987 hasConceptScore W108278987C31467283 @default.
• W108278987 hasConceptScore W108278987C501734568 @default.
• W108278987 hasConceptScore W108278987C54355233 @default.
• W108278987 hasConceptScore W108278987C67705224 @default.
• W108278987 hasConceptScore W108278987C71924100 @default.
• W108278987 hasConceptScore W108278987C86803240 @default.
• W108278987 hasLocation W1082789871 @default.
• W108278987 hasOpenAccess W108278987 @default.
• W108278987 hasPrimaryLocation W1082789871 @default.
• W108278987 hasRelatedWork W1667485879 @default.
• W108278987 hasRelatedWork W1942725639 @default.
• W108278987 hasRelatedWork W1969106027 @default.
• W108278987 hasRelatedWork W2015961470 @default.
• W108278987 hasRelatedWork W2037936888 @default.
• W108278987 hasRelatedWork W2060183340 @default.
• W108278987 hasRelatedWork W2066880317 @default.
• W108278987 hasRelatedWork W2086123259 @default.
• W108278987 hasRelatedWork W2107377540 @default.
• W108278987 hasRelatedWork W2112581675 @default.
• W108278987 hasRelatedWork W2139497502 @default.
• W108278987 hasRelatedWork W2183193907 @default.
• W108278987 hasRelatedWork W2265473778 @default.
• W108278987 hasRelatedWork W2297537489 @default.
• W108278987 hasRelatedWork W2887170399 @default.
• W108278987 hasRelatedWork W3028795290 @default.
• W108278987 hasRelatedWork W3146675191 @default.
• W108278987 hasRelatedWork W3149629448 @default.
• W108278987 hasRelatedWork W431499791 @default.
• W108278987 hasRelatedWork W2080562393 @default.
• W108278987 isParatext "false" @default.
• W108278987 isRetracted "false" @default.
• W108278987 magId "108278987" @default.
• W108278987 workType "dissertation" @default.